Sbi Securities Co., Ltd. Cassava Sciences Inc Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,449 shares of SAVA stock, worth $3,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,449
Previous 1,247
16.2%
Holding current value
$3,361
Previous $1.87 Million
40.19%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SAVA
# of Institutions
139Shares Held
13.9MCall Options Held
1.62MPut Options Held
1.25M-
Black Rock Inc. New York, NY3.22MShares$7.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$5.03 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny909KShares$2.11 Million0.0% of portfolio
-
State Street Corp Boston, MA874KShares$2.03 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY790KShares$1.83 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $93M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...